Biogen Inc. BIIB
253.25 USD -1.63 (-0.64%)
Nov 10, 2026, 9:37 AM EST
252.54 Day range 254.70
156.26 52-week range 254.87
- YTD
- +43.90%
- 1 year
- +62.07%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.89B | 9.68B | 9.84B | 10.17B | 10.98B | |
| 7.49B | 7.37B | 7.30B | 7.90B | 8.87B | |
| 1.56B | 1.91B | 1.30B | 3.59B | 1.75B | |
| 1.29B | 1.63B | 1.16B | 3.05B | 1.56B | |
| 8.79 | 11.18 | 7.97 | 20.87 | 10.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.01B | 2.38B | 1.05B | 3.42B | 2.26B | |
| 29.44B | 28.05B | 26.84B | 24.55B | 23.88B | |
| 11.18B | 11.33B | 12.05B | 11.17B | 12.92B | |
| 6.58B | 6.63B | 7.34B | 6.61B | 7.60B | |
| 18.26B | 16.72B | 14.80B | 13.40B | 10.90B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.20B | 2.88B | 1.55B | 1.38B | 3.64B | |
| -1.37B | -799.20M | -4.10B | 1.58B | -563.70M | |
| -301.90M | -683.50M | 149.30M | -1.75B | -2.09B | |
| -185.40M | -271.20M | -311.40M | 339.40M | -276.90M | |
| 531.60M | 1.39B | -2.40B | 1.21B | 990.00M |